Evidence map›Paper›PMID 21239626›Full record

ArticleEukaryotic cell2011

Role of glucose in the expression of Cryptococcus neoformans antiphagocytic protein 1, App1.

Virginia Williams, Maurizio Del Poeta

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Comparative genomics ofbioRxiv : the preprint server for biology · 2024
    Article
  5. Macrophage Mediated Immunomodulation DuringFrontiers in cellular and infection microbiology · 2022
    Review
  6. Review
  7. Low Glucose Mediated Fluconazole Tolerance inJournal of fungi (Basel, Switzerland) · 2021
    Article
  8. Review
  9. Targeting a critical step in fungal hexosamine biosynthesis.The Journal of biological chemistry · 2020
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Virginia WilliamsDepartment of Biochemistry & Molecular Biology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.
Maurizio Del Poeta
Medical University of South Carolina · US

Funding

Sphingolipid-mediated fungal pathogenesisR01AI056168 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI DEL POETA, MAURIZIO · 2004 to 2013
$2.7M
MUSC FACIL EXPANSION &RENOV: SLE C06RR015455 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2002 to 2002
$2.0M
Molecular Recognition Studies of the Interleukin-7 PathwayR01AI072142 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI WALSH, SCOTT T · 2008 to 2012
$1.6M
Molecular Recognition Studies of the Interleukin-7 PathwayR56AI072142 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI WALSH, SCOTT T · 2013 to 2013
$357k
NCRR NIH HHS C06 RR015455NIAID NIH HHS AI72142NIAID NIH HHS R01 AI056168NIAID NIH HHS R01 AI072142NIAID NIH HHS R01 AI56168NIAID NIH HHS R56 AI072142Wellcome Trust
6 · The paper itself

Abstract

The cryptococcus-specific protein antiphagocytic protein 1 (App1) regulates Cryptococcus neoformans virulence by controlling macrophage-driven fungal phagocytosis. This is accomplished through complement receptors (CR), specifically CR3. When inhaled, C. neoformans can cause a life-threatening meningoencephalitis in immunocompromised patients. Because glucose starvation can significantly change the gene expression and virulence of C. neoformans and because App1 is critical for phagocytosis in the lung-a low-glucose environment-we investigated the role of glucose in App1 expression. We found that App1 was upregulated dramatically under low-glucose conditions, and it was upregulated when C. neoformans cells were incubated in bronchoalveolar lavage (BAL) fluid, serum, and cerebrospinal fluid, which are low-glucose environments. Characterization of App1's regulation based on mammalian lung physiology revealed that App1 is upregulated via both increases in transcription and increases in mRNA stability. Our data provide new insights regarding C. neoformans adaptations to low-glucose environments.

Indexed as

Gene Expression Regulation, FungalAnimalsCarrier ProteinsCryptococcosisCryptococcus neoformansFemaleGlucoseHumansMaleMiceMice, Inbred CBAUp-RegulationVirulenceApp1 protein, Cryptococcus neoformansCarrier ProteinsGlucose

Identifiers

PMID21239626
PMCPMC3067477
OpenAlexW2156014844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.